Group One Trading
NYMX

Group One Trading’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Group One Trading’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,307
Closed -$1.01K – 8672
2023
Q2 		$1.01K Buy
5,307
+67
+1% +$26 ﹤0.01% 7255
2023
Q1 		$1.78K Buy
5,240
+300
+6% +$122 ﹤0.01% 6640
2022
Q4 		$1.47K Sell
4,940
-1,010
-17% -$366 ﹤0.01% 6741
2022
Q3 		$3K Buy
+5,950
New +$2.37K ﹤0.01% 7085
2022
Q2 		– Sell
-36,080
Closed -$33.2K – 8789
2022
Q1 		$45K Buy
36,080
+35,484
+5,954% +$54.8K ﹤0.01% 6173
2021
Q4 		$1K Sell
596
-21,433
-97% -$34.2K ﹤0.01% 8071
2021
Q3 		$45K Buy
22,029
+18,098
+460% +$32.1K ﹤0.01% 6629
2021
Q2 		$6K Buy
3,931
+2,900
+281% +$5.38K ﹤0.01% 7729
2021
Q1 		$2K Buy
1,031
+1,010
+4,810% +$2.66K ﹤0.01% 7421
2020
Q4 		$0 Sell
21
-1
-5% -$2 ﹤0.01% 7177
2020
Q3 		$0 Sell
22
-600
-96% -$1.75K ﹤0.01% 6695
2020
Q2 		$2K Sell
622
-5,000
-89% -$15.8K ﹤0.01% 5594
2020
Q1 		$13K Buy
5,622
+4,145
+281% +$11.6K ﹤0.01% 4473
2019
Q4 		$3K Buy
1,477
+1,400
+1,818% +$2.76K ﹤0.01% 4860
2019
Q3 		$0 Buy
+77
New +$135 ﹤0.01% 5692
2018
Q4 		– Sell
-10,207
Closed -$18.7K – 5580
2018
Q3 		$25K Sell
10,207
-3,200
-24% -$9.45K ﹤0.01% 4316
2018
Q2 		$45K Sell
13,407
-37,990
-74% -$146K ﹤0.01% 4012
2018
Q1 		$217K Sell
51,397
-37,975
-42% -$132K ﹤0.01% 2734
2017
Q4 		$295K Buy
89,372
+22,796
+34% +$83.1K ﹤0.01% 2656
2017
Q3 		$254K Buy
66,576
+47,649
+252% +$181K ﹤0.01% 2594
2017
Q2 		$83K Sell
18,927
-11,336
-37% -$46.6K ﹤0.01% 3233
2017
Q1 		$110K Buy
+30,263
New +$99.6K ﹤0.01% 2912
2016
Q3 		– Sell
-8,322
Closed -$27.2K – 5015
2016
Q2 		$28K Buy
8,322
+529
+7% +$1.3K ﹤0.01% 3637
2016
Q1 		$19K Sell
7,793
-34,152
-81% -$80.7K ﹤0.01% 3783
2015
Q4 		$138K Buy
41,945
+35,648
+566% +$120K ﹤0.01% 2774
2015
Q3 		$22K Sell
6,297
-7,399
-54% -$17.2K ﹤0.01% 3990
2015
Q2 		$18K Buy
13,696
+10,234
+296% +$14.3K ﹤0.01% 4080
2015
Q1 		$3K Sell
3,462
-7,507
-68% -$3.54K ﹤0.01% 4511
2014
Q4 		$4K Buy
10,969
+7,454
+212% +$15.9K ﹤0.01% 4562
2014
Q3 		$15K Buy
+3,515
New +$17.2K ﹤0.01% 4274
2014
Q2 		– Sell
-10,230
Closed -$52.7K – 5578
2014
Q1 		$56K Sell
10,230
-5,187
-34% -$30.1K ﹤0.01% 3555
2013
Q4 		$94K Buy
15,417
+3,322
+27% +$22.6K ﹤0.01% 3097
2013
Q3 		$80K Buy
12,095
+3,173
+36% +$20.7K ﹤0.01% 3208
2013
Q2 		$46K Buy
+8,922
New +$45.2K ﹤0.01% 3509

Other funds holding NYMX

DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
FCFC
First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
ODIJL
One Day In July LLC Burlington, Vermont $1.25B AUM 12.08% 1-Year Est. Return

Group One Trading's NYMX Position: Q3 2023 in Review

Group One Trading sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 5,307 shares — an estimated $1.01K sold.

Group One Trading first reported a position in NYMX in Q2 2013 and held it in 34 quarters. The position peaked at $295K in Q4 2017. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

  • Group One Trading reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 5,307 Nymox Pharmaceutical Corp shares in Q3 2023, an estimated $1.01K.
  • Group One Trading first reported a position in Nymox Pharmaceutical Corp in Q2 2013 and held it in 34 quarters.
  • Group One Trading's Nymox Pharmaceutical Corp position peaked at $295K in Q4 2017.
  • 5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.